Assessment of the risk of a decrease in the number of endothelial cells after the CyPass stent implantation, real-life study

Assessment of the risk of a decrease in the number of endothelial cells after the CyPass stent implantation, real-life study - CyPass Endothelium Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023580

Enrollment

500

Registered

2020-12-08

Start date

2020-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H40.1 H17

Interventions

Group 1: Patients who took part in the follow-up examination at the Neubrandenburg Eye Clinic after the CyPass stent was recalled.

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: All patients who came to the Clinic for Ophthalmology in Neubrandenburg for a check-up as part of the CyPass recall.

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

Measure	Time frame
Determination of the effect of the CyPass stent on the endothelial cell count and the cornea and their correlation with the stent position in the everyday practice of our own patients.	—

Secondary

Measure	Time frame
Determination of the proportion of necessary surgical interventions for safety after implantation of the CyPass stent.	—

Countries

Germany

Contacts

Public ContactAhmed Medra

Dietrich-Bonhoeffer-Klinikum Klinik für Augenheilkunde

medraa@dbknb.de0395/77513483

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026